AngioDynamics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
14 Plaza Dr, Latham, New York, 12110, Un...Phone Number
(518) 795-1400Website
www.angiodynamics.comRevenue
$313.7 MillionStock Symbol
ANGOIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
6
1
1
1
2
About AngioDynamics
Established in 1988, as a division of E-Z-EM, AngioDynamics is a company with a rich history thats defined by its innovation and growth as a committed medical community partner with a focus on developing high-quality medical devices that improve patient outcomes. AngioDynamics has a notable global presence, with worldwide operations. The companys commitment to advancing medical solutions has established a strong presence in key healthcare markets worldwide. Through strategic partnerships, distribution networks, and a diverse product portfolio, AngioDynamics continues to contribute to the improvement of patient outcomes on a global scale.Explore more
AngioDynamics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AngioDynamics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when AngioDynamics launches new products
AngioDynamics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once AngioDynamics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AngioDynamics
Click to see if AngioDynamics had a recent Job posting/layoffs
Earning: See what the market has to say on AngioDynamics recently announced quarterly report
Check if AngioDynamics has recently received funding, and reach out quickly before it becomes old news!
Check out if AngioDynamics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined AngioDynamics as Masked Content
Find 2 more new buyers
Compare Similar Companies to AngioDynamics
Compare insights from companies similar to AngioDynamics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AngioDynamics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AngioDynamics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AngioDynamics.
AngioDynamics financials insights
Gather financial insights about AngioDynamics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Stock Offering
$21.4M
2016
Debt
$250M
2022
Debt
$105M
AngioDynamics Tech Stack
A closer look at the technologies used by AngioDynamics
Most Recent Scoops
Person-Based
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
AngioDynamics has more open roles in Sales than it has had at any time in the past 9 months. Technologies mentioned include: Salesforce.
Hiring Plans
Hiring Plans
AngioDynamics has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Medical Devices, and Physician Credentialing.
Hiring Plans
Person-Based
Earnings, Business Finance, Finance
AngioDynamics News & Media
AngioDynamics alleges clot removal patent infringement by E2 - MassDevice
AngioDynamics has filed a lawsuit against Endovascular Engineering (E2) in the U.S. District Court for the District of Delaware.AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf
AngioDynamics (NASDAQ:ANGO) CEO Jim Clemmer used a presentation at Needham & Company’s 25th Annual Needham Healthcare Conference to outline the company’s multi-year transformation, highlight growth drivers in its MedTech segment, and discuss clinical and commercial plans for its three primary plAngioDynamics Q3 Earnings Call Highlights
AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 third-quarter results that management described as “strong across the board,” highlighted by faster growth in its MedTech segment and improved adjusted EBITDA. The company also raised its full-year outlook for net sales and adjusted EBITDA for the thiAngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AngioDynamics, Inc. (ANGO) 44th Annual J.P.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding AngioDynamics
Sign Up For FreeTo access detailed company insights
Established in 1988, as a division of E-Z-EM, AngioDynamics is a company with a rich history thats defined by its innovation and growth as a committed medical community partner with a focus on developing high-quality medical devices that improve patient outcomes. AngioDynamics has a notable global presence, with worldwide operations. The companys c... Read More
